A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers.

被引：3

作者：

Blagden, Sarah Patricia

Rizzuto, Ivana

Stavraka, Chara

O'Shea, Daniel

Suppiah, Puvan

Patel, Markand

Loyse, Naomi

Sukumaran, Ajithkumar

Bharwani, Nishat

Rockall, Andrea

Gabra, Hani

El-Bahrawy, Mona

Wasan, Harpreet S.

Leonard, Robert C. F.

Habib, Nagy A.

McGuigan, Christopher

Gribben, John G.

Ghazaly, Essam Ahmed

机构：

[1] Ovarian Canc Act Res Ctr, London, England

[2] Imperial Clin Res Facil, NIHR Wellcome Trust, London, England

[3] Imperial CRF, NIHR Wellcome Trust, London, England

[4] Dept Radiol, London, England

[5] Univ London Imperial Coll Sci Technol & Med, London, England

[6] Charing Cross Hosp, Chalfont, England

[7] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales

[8] Queen Mary Univ London, Ctr Haematooncol, Barts Canc Inst, London, England

来源：

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.2547

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2547

引用

页数：1